Risk factors of severe COVID-19: a review of host, viral and environmental factors
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …
asymptomatic infections to severe disease and death. Understanding the risk factors of …
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe
CI Vardavas, AG Mathioudakis… - European …, 2022 - Eur Respiratory Soc
Background As mortality from coronavirus disease 2019 (COVID-19) is strongly age-
dependent, we aimed to identify population subgroups at an elevated risk for adverse …
dependent, we aimed to identify population subgroups at an elevated risk for adverse …
Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis
E Karakike, EJ Giamarellos-Bourboulis… - Critical care …, 2021 - journals.lww.com
Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ …
respiratory tract infection, which can induce respiratory failure and multiple organ …
[HTML][HTML] Peer Reviewed: COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis
R Nagarajan, Y Krishnamoorthy, S Rajaa… - Preventing Chronic …, 2022 - ncbi.nlm.nih.gov
Methods We searched for studies reporting COVID-19 outcomes among CLD and non-CLD
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
J Xu, W Xiao, X Liang, L Shi, P Zhang, Y Wang… - BMC public health, 2021 - Springer
Background Cardiovascular disease (CVD), one of the most common comorbidities of
coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse …
coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse …
Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19
M Bucholc, D Bradley, D Bennett, L Patterson… - Scientific reports, 2022 - nature.com
We investigated the association between a wide range of comorbidities and COVID-19 in-
hospital mortality and assessed the influence of multi morbidity on the risk of COVID-19 …
hospital mortality and assessed the influence of multi morbidity on the risk of COVID-19 …
COVID-19: A redox disease—What a stress pandemic can teach us about resilience and what we may learn from the reactive species interactome about its treatment
AF Cumpstey, AD Clark, J Santolini… - Antioxidants & Redox …, 2021 - liebertpub.com
Significance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
causing coronavirus disease 2019 (COVID-19), affects every aspect of human life by …
causing coronavirus disease 2019 (COVID-19), affects every aspect of human life by …
Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 …
A Marrone, R Nevola, A Sellitto… - Clinical Infectious …, 2022 - academic.oup.com
Background Remdesivir is an antiviral used to treat coronavirus disease 2019 (COVID-19),
which improves some clinical outcomes. Dexamethasone has been shown to be effective in …
which improves some clinical outcomes. Dexamethasone has been shown to be effective in …
Abnormal liver biochemistry tests and acute liver injury in COVID-19 patients: current evidence and potential pathogenesis
DA McGrowder, F Miller, M Anderson Cross… - Diseases, 2021 - mdpi.com
Globally, millions of persons have contracted the coronavirus disease 2019 (COVID-19)
over the past several months, resulting in significant mortality. Health care systems are …
over the past several months, resulting in significant mortality. Health care systems are …
[HTML][HTML] Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study
S Afify, B Eysa, FA Hamid, OM Abo-Elazm… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Chronic liver disease, particularly cirrhosis, is associated with worse
outcomes in patients infected with coronavirus disease 2019 (COVID-19). AIM To assess …
outcomes in patients infected with coronavirus disease 2019 (COVID-19). AIM To assess …